Roth/MKM on Fortress Biotech (FBIO): 'Multiple Catalysts on Tap for 2024'
Tweet Send to a Friend
Roth/MKM analyst Jason Whittes reiterated a Buy rating and $10.00 price target on Fortress Biotech (NASDAQ: FBIO).The analyst comments "Fortress ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
